REG - Palace Capital PLC - Disposal Update

Palace CapitalAnnouncement

09/02/2026 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260209:nRSI1431Sa&default-theme=true

RNS Number : 1431S  Palace Capital PLC  09 February 2026

9 February 2026

Palace Capital plc

("Palace Capital" or the "Company")

DISPOSAL UPDATE

The Company has unconditionally exchanged on the sale of its investment
property at Broad Street Plaza, Halifax for £9.9 million at a 14.9.% net
initial yield ("NIY"). The sale price is 8.7% ahead of the September 2025
valuation. Completion is expected in the next few weeks.

The Company announced in April 2025 the disposal of Units 5&6b, Broad
Street Plaza, Halifax, on a long leasehold interest for £4.8 million to
Calderdale and Huddersfield NHS Foundation Trust, at a 7.5% NIY. On completion
of the disposal announced today, the Company will have disposed of all of its
interests in Halifax.

The Company has also exchanged and completed on the sale of unit 3A, St.
James' Gate, Newcastle for £0.59 million.

Further updates will be made in due course.

 

Palace Capital plc
Christian Kappelhoff-Wulff, Non-Executive Chairman
ckw@palacecapitalplc.com (mailto:ckw@palacecapitalplc.com)

Financial PR
FTI Consulting

Dido Laurimore / Andrew Davies

Tel: +44 (0)20 3727 1000
palacecapital@fticonsulting.com (mailto:palacecapital@fticonsulting.com)

 

This announcement contains inside information for the purposes of Article 7 of
the UK version of the Market Abuse Regulation (EU) No. 596/2014 as it forms
part of UK law by virtue of the European Union (Withdrawal) Act 2018, as
amended.

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DISSSIFMAEMSEFE



            Copyright 2019 Regulatory News Service, all rights reserved